Last updated: 2026-09-27 13:31:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Eli Lilly & Co. (LLY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1.183,81, with a market capitalization of $1,05T and a P/E ratio of 39,49. Over the past 52 weeks, its price has ranged from $716,08 to $1.292,65. This page covers its latest market performance, valuation, price trends and company information.
$1,05T | |
$1.185,32 | |
$1.292,65 | |
$27,21 | |
$1.181,89 | |
1,42M | |
2,57M | |
39,49 | |
$1.292,65 | |
$716,08 | |
0,55% | |
-- |
Eli Lilly & Co. (LLY) last closed at $1.181,89 as of 2026-09-25 23:46:27, unchanged from the previous close of $1.181,89.
During the latest regular trading session, LLY traded between $27,21 and $1.292,65, with a volume of 1,42M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Eli Lilly & Co. (LLY) moved from $1.152,44 to $1.183,81, representing a gain of 2,72% ($31,37).
The stock traded between $1.134,41 and $1.197,79 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 2,55 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 81,1%
LLY is currently trading at $1.183,81, placing it 81,1% of the way from its 52-week low of $716,08 to its 52-week high of $1.292,65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 50000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Eli Lilly & Co. (LLY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.